Xofluza – Approved Flu Treatment

A box of new flu drug Xofluza.

In October 2018, the U.S. Food and Drug Administration approved Xofluza as a treatment for uncomplicated acute influenza (the flu). To test the safety and effectiveness of Xofluza, the FDA organized two randomized controlled clinical trials where 1,832 patients above the age of 12 participated. During this process, the participants were either given Xofluza, a placebo, or another flu treatment, within the first 48 hours of experiencing symptoms of the flu.

During both of the organized clinical trials, the participants that took Xofluza experienced their symptoms for a shorter amount of time compared to those who took the placebo. On the other hand, those that took the other flu treatment experienced alleviation of their symptoms in the same amount of time of those that took Xofluza.

From this discovery, the FDA concluded that Xofluza is an approved antiviral flu treatment that will help improve an individual’s symptoms of the flu if taken within the first 48 hours of becoming sick. That said, Xofluza is not a substitute for your yearly flu vaccination. Instead, Xofluza helps to treat your symptoms and decrease the time you may feel sick, while a yearly flu vaccination helps to protect yourself and loved ones from flu outbreaks.

Since influenza is a contagious respiratory virus, a sinus doctor may prescribe Xofluza if you have been experiencing symptoms of the flu for less than 48 hours. Some symptoms of the flu include fever, aches, chills, and more. If you or a loved one are experiencing flu symptoms, please do not hesitate to call our providers at Columbia Allergy and Asthma Specialists. Our doctors can help improve your symptoms, by prescribing you Xofluza or a similar approved flu treatment. By taking a one-time dose of Xofluza, you should recover from your flu symptoms within approximately 2-3 days. Feel free to learn more about the FDA approved flu treatment, Xofluza, or contact us today to schedule an appointment.